Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
UNC:ETR
UCB SA
€224,30
-0,04%
(-0,100) 1D
29 Apr., 14:32:02 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for UNC...
Mkt. cap
44,35 mjd
Avg. vol.
86,00
Volume
52,00
Dividend
0,45%
Quarterly dividend
€0,25
Ex dividend date
04 Mei 2026
P/E ratio
27,96
52-wk high
€287,20
52-wk low
€203,00
EPS
€8,02
No. of employees
10 k
News stories
From sources across the web
Profile
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology. Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
About UCB SA
CEOJean-Christophe Tellier
Employees9,76 k
Founded18 Jan. 1928
Headquarters-
SectorPharmaceutical industry
Websiteucb.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
1,74 mjd
1,74 mjd
2,13 mjd
2,13 mjd
Cost of goods sold
461,00 m
461,00 m
534,00 m
534,00 m
Cost of revenue
461,00 m
461,00 m
534,00 m
534,00 m
Research and development expenses
430,00 m
430,00 m
481,00 m
481,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
639,00 m
639,00 m
735,50 m
735,50 m
Operating expense
935,50 m
935,50 m
946,50 m
946,50 m
Total operating expenses
1,40 mjd
1,40 mjd
1,48 mjd
1,48 mjd
Operating income
347,00 m
347,00 m
646,50 m
646,50 m
Other non operating income
-40,50 m
-40,50 m
36,00 m
36,00 m
EBT including unusual items
296,50 m
296,50 m
614,50 m
614,50 m
EBT excluding unusual items
308,00 m
308,00 m
622,50 m
622,50 m
Income tax expense
59,00 m
59,00 m
73,00 m
73,00 m
Effective tax rate
19,90%
19,90%
11,88%
11,88%
Other operating expenses
-133,50 m
-133,50 m
-270,00 m
-270,00 m
Net income
237,50 m
237,50 m
541,50 m
541,50 m
Net profit margin
13,62%
13,62%
25,46%
25,46%
Earnings per share
-
-
-
-
Interest and investment income
40,00 m
40,00 m
-
-
Interest expense
-21,50 m
-21,50 m
-58,00 m
-58,00 m
Net interest expenses
18,50 m
18,50 m
-58,00 m
-58,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
503,50 m
503,50 m
803,50 m
803,50 m
Gain or loss from assets sale
-
-
1,00 m
1,00 m
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer